Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials-Reference-Cited by-同舟云学术

Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials

Published:2009-01-01 Issue:1 Volume:32 Page:187-192
ISSN:0149-5992
Container-title:Diabetes Care
language:en
Short-container-title:

Author:

Skyler Jay S.¹,Bergenstal Richard²,Bonow Robert O.³,Buse John⁴,Deedwania Prakash⁵,Gale Edwin A.M.⁶,Howard Barbara V.⁶⁷,Kirkman M. Sue⁸,Kosiborod Mikhail⁹,Reaven Peter¹⁰,Sherwin Robert S.¹¹

Affiliation:

1. University of Miami, Miami, Florida

2. International Diabetes Center at Park Nicollet, Minneapolis, Minnesota

3. Northwestern University Feinberg School of Medicine, Chicago, Illinois

4. University of North Carolina, Chapel Hill, North Carolina

5. VA Central California Healthcare System, University of California San Francisco, Fresno, California

6. University of Bristol, Bristol, U.K.

7. MedStar Research Institute, Hyattsville, Maryland

8. American Diabetes Association, Alexandria, Virginia

9. Mid America Heart Institute of Saint Luke's Hospital and the University of Missouri-Kansas City, Kansas City, Missouri

10. Carl T. Hayden VA Medical Center, Phoenix, Arizona

11. Yale University School of Medicine, New Haven, Connecticut

Publisher

American Diabetes Association

Subject

Advanced and Specialized Nursing,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://diabetesjournals.org/care/article-pdf/32/1/187/600266/zdc00109000187.pdf

Reference16 articles.

1. Reichard P, Bengt-Nilsson B-Y, Rosenqvist U: The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 329:304–309, 1993

2. Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977–986, 1993

3. Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S, Kojima Y, Furuyoshi N, Shichiri M: Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 28:103–117, 1995

4. UK Prospective Diabetes Study (UKPDS) Group: Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 352:854–865, 1998

5. UK Prospective Diabetes Study (UKPDS) Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837–853, 1998

Cited by 683 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glycaemic control is still central in the hierarchy of priorities in type 2 diabetes management;Diabetologia;2024-08-19

2. Acute Psychological Stress Detection Using Explainable Artificial Intelligence for Automated Insulin Delivery;Signals;2024-07-30

3. Type 2 diabetes in children and adolescents: Exploring the disease heterogeneity and research gaps to optimum management;World Journal of Clinical Pediatrics;2024-06-09

4. Overview and comparison of contemporary Society for Vascular Surgery, American Heart Association/American College of Cardiology, and European Society for Vascular Surgery guidelines for the management of patients with intermittent claudication;Seminars in Vascular Surgery;2024-06

5. Diabetes and Stroke: Impact of Novel Therapies for the Treatment of Type 2 Diabetes Mellitus;Biomedicines;2024-05-16